General Archive
-
News releasesLifeArc and Cleveland Clinic join forces to develop new monoclonal antibody therapeutics for patients with high unmet medical needs
LifeArc and Cleveland Clinic, a nonprofit, multispecialty academic medical centre, have signed a new 10-year Master Services Agreement (MSA) for…
-
Funding call for innovations for exceptionally low-cost monoclonal antibody (mAb) manufacturing
Funding: Call for innovations for exceptionally low-cost monoclonal antibody (mAb) manufacturing In partnership with The Gates Foundation, we are requesting…
-
LifeArc antibody showcase at Babraham Research Campus
About the showcase We are hosting a roadshow to showcase the capabilities of our newly launched antibody discovery platform, B-SMART™,…
-
Protein and Antibody Engineering Europe Summit
About the event The Protein and Antibody Engineering Europe Summit is the largest protein and antibody engineering event in Europe,…
-
Pharma Integrates
About the event Pharma Integrates is a premier event uniting leaders across the pharmaceutical pipeline to address their needs, exchange…
-
News releasesTwo major UK decisions announced on use of Alzheimer’s drug, lecanemab
Today, two major decisions have been made on lecanemab (Leqembi®) – the Alzheimer’s drug that we helped humanise, which slows the…
-
Articles & blogsLifeArc contributes to organic chemistry breakthrough
The findings reveal that seemingly impossible chemical reactions can be driven through a phenomenon called quantum tunnelling.
-
Articles & blogsStudy reveals potential new way to treat colorectal cancer
Scientists discovered an IL-17B receptor antibody could be used to treat colorectal cancer.
-
LifeArc collaboration helps to advance a potential new cancer drug towards the clinic
Making our unique ULK inhibitors available as tools for the academic community has helped to reignite interest in blocking autophagy…
-
Exploring new approaches to drug discovery
LifeArc’s scientists have been working on a fresh approach to drug discovery, using a parallel high-throughput application to significantly improve…
-
Rising to the challenge of COVID-19
While the development of COVID-19 vaccines has garnered much attention, scientists have also been looking at repurposed medicines as an…
-
How to kill a virus: LifeArc’s role in shaping the UK’s COVID-19 response
In 2020 the UK Government, supported by UK Research and Innovation and the National Institute for Health and Research, launched…